Sergio Coffa

Array ( [id] => 10954536 [patent_doc_number] => 20140357557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/291745 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 67440 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739762 [patent_doc_number] => 20140275479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOEITIN-2' [patent_app_type] => utility [patent_app_number] => 14/290531 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 48591 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926725 [patent_doc_number] => 20140329747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Compositions and Methods for Treating Renal Failure' [patent_app_type] => utility [patent_app_number] => 14/263526 [patent_app_country] => US [patent_app_date] => 2014-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7508 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14263526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10135976 [patent_doc_number] => 09169289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation' [patent_app_type] => utility [patent_app_number] => 14/257255 [patent_app_country] => US [patent_app_date] => 2014-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10082 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14257255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926735 [patent_doc_number] => 20140329756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'TEMPERATURE-RELEASE CATALYST FOR CROSS-LINKING HALYURONIC ACID DURING INJECTION' [patent_app_type] => utility [patent_app_number] => 14/255963 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6971 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785237 [patent_doc_number] => 20140302057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'INHIBITORS OF METASTASIS' [patent_app_type] => utility [patent_app_number] => 14/246864 [patent_app_country] => US [patent_app_date] => 2014-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15443 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699436 [patent_doc_number] => 20160045582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'CONJUGATE VACCINE USING TRIMMING FUNCTION OF ERAP1' [patent_app_type] => utility [patent_app_number] => 14/780241 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 42184 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9603035 [patent_doc_number] => 20140199717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'Multiplex MRM Assay for Evaluation of Cancer' [patent_app_type] => utility [patent_app_number] => 14/223524 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7492 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10715687 [patent_doc_number] => 20160061835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'IDENTIFICATION AND CHARACTERIZATION OF A PEPTIDE AFFINITY REAGENT FOR THE DETECTION OF NOROVIRUSES IN CLINICAL SAMPLES' [patent_app_type] => utility [patent_app_number] => 14/777714 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8711 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9615816 [patent_doc_number] => 20140205673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'PRODUCT FOR PARENTERAL NUTRITION OF OBESE INTENSIVE-CARE PATIENTS' [patent_app_type] => utility [patent_app_number] => 14/221408 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12831 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656172 [patent_doc_number] => 20160002315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'APOLIPOPROTEIN MIMETICS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/770270 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33545 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693726 [patent_doc_number] => 20160039872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'PEPTIDE AND PEPTIDE MIMETIC BINDING ANTAGONISTS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/776512 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32691 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14975353 [patent_doc_number] => 10441560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Compositions and methods for treating non-alcoholic steatohepatitis [patent_app_type] => utility [patent_app_number] => 14/209964 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 20499 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10911761 [patent_doc_number] => 20140314778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'FORMULATIONS WITH REDUCED OXIDATION' [patent_app_type] => utility [patent_app_number] => 14/207911 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30736 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14207911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693734 [patent_doc_number] => 20160039881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'SITE-SELECTIVE FUNCTIONALIZATION OF GLYCOPEPTIDE ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 14/776336 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22963 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10911675 [patent_doc_number] => 20140314691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'COMPOSITIONS FOR IMPROVING THE APPEARANCE AND/OR HEALTH OF TEETH' [patent_app_type] => utility [patent_app_number] => 14/205098 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15122 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757306 [patent_doc_number] => 20140288006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'PTD-SMAD7 THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/201488 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 37816 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11828751 [patent_doc_number] => 09725484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Methods and compositions for the treatment of bone remodeling disorders' [patent_app_type] => utility [patent_app_number] => 14/770276 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 9851 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14794051 [patent_doc_number] => 10400018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Tau peptides, anti-tau antibodies, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/117268 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 21 [patent_no_of_words] => 70499 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735894 [patent_doc_number] => 20140271606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'METHODS OF USING ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING BLEEDING DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/180113 [patent_app_country] => US [patent_app_date] => 2014-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5152 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14180113 [rel_patent_id] =>[rel_patent_doc_number] =>)